{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:59:44Z","timestamp":1789084784113,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04440-2","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:07:53Z","timestamp":1741180073000},"page":"2613-2624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The global burden of chronic kidney disease due to glomerulonephritis: trends and predictions"],"prefix":"10.1007","volume":"57","author":[{"given":"Xiaotong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"4440_CR1","doi-asserted-by":"crossref","unstructured":"KDIGO (2024) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4s):S117\u2013S314","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"2","key":"4440_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000534071","volume":"148","author":"M Ying","year":"2024","unstructured":"Ying M et al (2024) Disease burden and epidemiological trends of chronic kidney disease at the global, regional, national levels from 1990 to 2019. Nephron 148(2):113\u2013123","journal-title":"Nephron"},{"issue":"3","key":"4440_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s40620-024-01914-x","volume":"37","author":"X Qing","year":"2024","unstructured":"Qing X et al (2024) Temporal trends in prevalence and disability of chronic kidney disease caused by specific etiologies: an analysis of the Global Burden of Disease Study 2019. J Nephrol 37(3):723\u2013737","journal-title":"J Nephrol"},{"key":"4440_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003143","author":"J Chen","year":"2024","unstructured":"Chen J et al (2024) Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040. Chin Med J (Engl). https:\/\/doi.org\/10.1097\/CM9.0000000000003143","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"4440_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/jcm13030678","volume":"13","author":"F Mallamaci","year":"2024","unstructured":"Mallamaci F, Tripepi G (2024) Risk factors of chronic kidney disease progression: between old and new concepts. J Clin Med 13(3):678","journal-title":"J Clin Med"},{"issue":"11","key":"4440_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41581-023-00747-4","volume":"19","author":"C Zoccali","year":"2023","unstructured":"Zoccali C et al (2023) Diagnosis of cardiovascular disease in patients with chronic kidney disease. Nat Rev Nephrol 19(11):733\u2013746","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"4440_CR7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/ndt\/gfae034","volume":"39","author":"S AbdElHafeez","year":"2024","unstructured":"AbdElHafeez S et al (2024) Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA registry. Nephrol Dial Transplant 39(9):1449\u20131460","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"4440_CR8","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s11255-022-03111-w","volume":"54","author":"Z Chen","year":"2022","unstructured":"Chen Z et al (2022) Prognostic analysis of crescentic glomerulonephritis with acute kidney injury: a single-center cohort with 5-year follow-up. Int Urol Nephrol 54(9):2375\u20132383","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"4440_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12882-020-01836-3","volume":"21","author":"A AlYousef","year":"2020","unstructured":"AlYousef A et al (2020) Glomerulonephritis histopathological pattern change. BMC Nephrol 21(1):186","journal-title":"BMC Nephrol"},{"key":"4440_CR10","first-page":"7","volume":"543","author":"ML Paul","year":"2024","unstructured":"Paul ML (2024) Renal and urinary conditions: glomerulonephritis. FP Essent 543:7\u201311","journal-title":"FP Essent"},{"issue":"8","key":"4440_CR11","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s40620-023-01697-7","volume":"36","author":"P Claudio","year":"2023","unstructured":"Claudio P, Gabriella M (2023) Nephrotic syndrome: pathophysiology and consequences. J Nephrol 36(8):2179\u20132190","journal-title":"J Nephrol"},{"issue":"12","key":"4440_CR12","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s11255-017-1719-3","volume":"49","author":"S Mirioglu","year":"2017","unstructured":"Mirioglu S et al (2017) Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival. Int Urol Nephrol 49(12):2265\u20132272","journal-title":"Int Urol Nephrol"},{"key":"4440_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/IJNRD.S391779","volume":"17","author":"MV de Sousa","year":"2024","unstructured":"de Sousa MV (2024) Post-transplant glomerulonephritis: challenges and solutions. Int J Nephrol Renovasc Dis 17:81\u201390","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"1","key":"4440_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2215\/CJN.0000000000000017","volume":"18","author":"J Hu","year":"2023","unstructured":"Hu J et al (2023) Global, regional, and national burden of CKD due to glomerulonephritis from 1990 to 2019: a systematic analysis from the global burden of disease study 2019. Clin J Am Soc Nephrol 18(1):60\u201371","journal-title":"Clin J Am Soc Nephrol"},{"key":"4440_CR15","unstructured":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403(10440):2133\u20132161"},{"issue":"9","key":"4440_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1542\/pir.2021-005259","volume":"44","author":"VS Keskinyan","year":"2023","unstructured":"Keskinyan VS, Lattanza B, Reid-Adam J (2023) Glomerulonephritis. Pediatr Rev 44(9):498\u2013512","journal-title":"Pediatr Rev"},{"key":"4440_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102829","volume":"76","author":"Z Luo","year":"2024","unstructured":"Luo Z et al (2024) Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021. EClinicalMedicine 76:102829","journal-title":"EClinicalMedicine"},{"key":"4440_CR18","doi-asserted-by":"publisher","first-page":"1501690","DOI":"10.3389\/fendo.2024.1501690","volume":"15","author":"KJ He","year":"2024","unstructured":"He KJ et al (2024) Global burden of type 2 diabetes mellitus from 1990 to 2021, with projections of prevalence to 2044: a systematic analysis across SDI levels for the global burden of disease study 2021. Front Endocrinol (Lausanne) 15:1501690","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4440_CR19","unstructured":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403(10440):2162\u20132203"},{"key":"4440_CR20","doi-asserted-by":"publisher","first-page":"1098218","DOI":"10.3389\/fonc.2022.1098218","volume":"12","author":"S Khanmohammadi","year":"2022","unstructured":"Khanmohammadi S et al (2022) Burden of tracheal, bronchus, and lung cancer in North Africa and Middle East countries, 1990 to 2019: results from the GBD study 2019. Front Oncol 12:1098218","journal-title":"Front Oncol"},{"issue":"1","key":"4440_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12889-021-10635-w","volume":"21","author":"Y Cui","year":"2021","unstructured":"Cui Y et al (2021) Trend dynamics of thyroid cancer incidence among China and the U.S. adult population from 1990 to 2017: a joinpoint and age\u2013period\u2013cohort analysis. BMC Public Health 21(1):624","journal-title":"BMC Public Health"},{"key":"4440_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102804","volume":"75","author":"Z Kuang","year":"2024","unstructured":"Kuang Z et al (2024) Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021. EClinicalMedicine 75:102804","journal-title":"EClinicalMedicine"},{"issue":"4","key":"4440_CR23","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1097\/JS9.0000000000001054","volume":"110","author":"Z Li","year":"2024","unstructured":"Li Z et al (2024) Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15\u201349 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study. Int J Surg 110(4):1929\u20131940","journal-title":"Int J Surg"},{"key":"4440_CR24","doi-asserted-by":"publisher","first-page":"204201882412272","DOI":"10.1177\/20420188241227295","volume":"15","author":"T Han","year":"2024","unstructured":"Han T et al (2024) Epidemiology of gout\u2014Global burden of disease research from 1990 to 2019 and future trend predictions. Ther Adv Endocrinol Metab 15:20420188241227296","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"4440_CR25","doi-asserted-by":"publisher","first-page":"2328521","DOI":"10.1080\/07853890.2024.2328521","volume":"56","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024) Global burden of liver cirrhosis 1990\u20132019 and 20 years forecast: results from the global burden of disease study 2019. Ann Med 56(1):2328521","journal-title":"Ann Med"},{"issue":"1","key":"4440_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41581-023-00784-z","volume":"20","author":"NC Chesnaye","year":"2024","unstructured":"Chesnaye NC et al (2024) Differences in the epidemiology, management and outcomes of kidney disease in men and women. Nat Rev Nephrol 20(1):7\u201320","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"4440_CR27","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2215\/CJN.04400419","volume":"14","author":"M Antlanger","year":"2019","unstructured":"Antlanger M et al (2019) Sex differences in kidney replacement therapy initiation and maintenance. Clin J Am Soc Nephrol 14(11):1616\u20131625","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"4440_CR28","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.2215\/CJN.11030919","volume":"14","author":"LA Tomlinson","year":"2019","unstructured":"Tomlinson LA, Clase CM (2019) Sex and the incidence and prevalence of kidney disease. Clin J Am Soc Nephrol 14(11):1557\u20131559","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"4440_CR29","first-page":"351","volume":"15","author":"SS EftekharVaghefi","year":"2021","unstructured":"EftekharVaghefi SS et al (2021) Sex-related changes in circadian rhythm of inflammatory and oxidative stress markers in CKD. Iran J Kidney Dis 15(5):351\u2013363","journal-title":"Iran J Kidney Dis"},{"issue":"10","key":"4440_CR30","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1681\/ASN.2022030373","volume":"33","author":"O Swartling","year":"2022","unstructured":"Swartling O et al (2022) Sex differences in the recognition, monitoring, and management of CKD in health care: an observational cohort study. J Am Soc Nephrol 33(10):1903\u20131914","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4440_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/nep.14137","volume":"28","author":"J Bai","year":"2023","unstructured":"Bai J et al (2023) Gender and socioeconomic disparities in global burden of chronic kidney disease due to glomerulonephritis: a global analysis. Nephrology (Carlton) 28(3):159\u2013167","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"4440_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2023.151316","volume":"42","author":"U Ekrikpo","year":"2022","unstructured":"Ekrikpo U et al (2022) Epidemiology and outcomes of glomerular diseases in low- and middle-income countries. Semin Nephrol 42(5):151316","journal-title":"Semin Nephrol"},{"issue":"7","key":"4440_CR33","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.34067\/KID.0000000000000489","volume":"5","author":"R Kalyesubula","year":"2024","unstructured":"Kalyesubula R et al (2024) The future of kidney care in low- and middle-income countries: challenges, triumphs, and opportunities. Kidney360 5(7):1047\u20131061","journal-title":"Kidney360"},{"issue":"5","key":"4440_CR34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00467-023-06129-z","volume":"39","author":"LE Roberts","year":"2024","unstructured":"Roberts LE et al (2024) Kidney transplantation in low- and middle-income countries: the transplant links experience. Pediatr Nephrol 39(5):1347\u20131353","journal-title":"Pediatr Nephrol"},{"key":"4440_CR35","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1046\/j.1523-1755.63.s83.19.x","volume":"83","author":"EL Bamgboye","year":"2003","unstructured":"Bamgboye EL (2003) Hemodialysis: management problems in developing countries, with Nigeria as a surrogate. Kidney Int Suppl 83:S93\u2013S95","journal-title":"Kidney Int Suppl"},{"key":"4440_CR36","doi-asserted-by":"crossref","unstructured":"Ip Min Wan D, Fagoonee K (2021) Global dialysis perspective: mauritius. Kidney360 2(6):1021\u20131026","DOI":"10.34067\/KID.0000982021"},{"issue":"2","key":"4440_CR37","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.kisu.2021.01.003","volume":"11","author":"E Zakharova","year":"2021","unstructured":"Zakharova E et al (2021) International society of nephrology global kidney health atlas: structures, organization, and services for the management of kidney failure in Newly Independent States and Russia. Kidney Int Suppl (2011) 11(2):e57\u2013e65","journal-title":"Kidney Int Suppl (2011)"},{"issue":"10","key":"4440_CR38","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s11255-023-03536-x","volume":"55","author":"E Ozkan","year":"2023","unstructured":"Ozkan E et al (2023) Comparison of focal segmental glomerulosclerosis and other primary glomerulonephrites in terms of parameters of hepatic steatosis and metabolic syndrome. Int Urol Nephrol 55(10):2557\u20132566","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"4440_CR39","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1007\/s11255-024-04066-w","volume":"56","author":"B Demirelli","year":"2024","unstructured":"Demirelli B et al (2024) Non-diabetic nephropathy in diabetic patients: incidence, HbA1c variability and other predictive factors, and implications. Int Urol Nephrol 56(9):3091\u20133100","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"4440_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40620-020-00733-0","volume":"34","author":"M Simeoni","year":"2021","unstructured":"Simeoni M et al (2021) Atherosclerotic-nephropathy: an updated narrative review. J Nephrol 34(1):125\u2013136","journal-title":"J Nephrol"},{"key":"4440_CR41","doi-asserted-by":"publisher","first-page":"1095211","DOI":"10.3389\/fendo.2022.1095211","volume":"13","author":"T Arabi","year":"2022","unstructured":"Arabi T et al (2022) Obesity-related kidney disease: beyond hypertension and insulin-resistance. Front Endocrinol (Lausanne) 13:1095211","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4440_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.xkme.2020.09.005","volume":"3","author":"EY Jimenez","year":"2021","unstructured":"Jimenez EY et al (2021) Medical nutrition therapy access in CKD: a cross-sectional survey of patients and providers. Kidney Med 3(1):31-41.e1","journal-title":"Kidney Med"},{"issue":"3","key":"4440_CR43","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","volume":"35","author":"NWS Chew","year":"2023","unstructured":"Chew NWS et al (2023) The global burden of metabolic disease: data from 2000 to 2019. Cell Metab 35(3):414-428.e3","journal-title":"Cell Metab"},{"key":"4440_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102848","volume":"76","author":"XD Zhou","year":"2024","unstructured":"Zhou XD et al (2024) Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021. EClinicalMedicine 76:102848","journal-title":"EClinicalMedicine"},{"issue":"4","key":"4440_CR45","volume":"46","author":"B Beir\u00e3o","year":"2024","unstructured":"Beir\u00e3o B et al (2024) C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: a diagnostic and therapeutic challenge. J Bras Nefrol 46(4):e20240092","journal-title":"J Bras Nefrol"},{"issue":"1","key":"4440_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1681\/ASN.0000000000000242","volume":"35","author":"K El Karoui","year":"2024","unstructured":"El Karoui K, Fervenza FC, De Vriese AS (2024) Treatment of IgA nephropathy: a rapidly evolving field. J Am Soc Nephrol 35(1):103\u2013116","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4440_CR47","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.47391\/JPMA.10666","volume":"74","author":"MB Mobin","year":"2024","unstructured":"Mobin MB, Zafar H (2024) Advancements in immunotherapy for glomerulonephritis: promising treatments on the horizon. J Pak Med Assoc 74(5):1034","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"4440_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2020.10.012","volume":"99","author":"MG Shlipak","year":"2021","unstructured":"Shlipak MG et al (2021) The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 99(1):34\u201347","journal-title":"Kidney Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04440-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04440-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:01:07Z","timestamp":1757152867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04440-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4440"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04440-2","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}